OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Pulmonary Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	46
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	35
The persistent problem of persistent air-leaks: approach to management	33
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	33
Home monitoring in asthma: towards digital twins	30
Bronchoscopic treatment of early-stage peripheral lung cancer	30
The role of PET in the management of sarcoidosis	28
Improving care in lung cancer surgery: a review of quality measures and evolving standards	24
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	22
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	22
Digital outcome measures in pulmonary clinical trials	22
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	22
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	20
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	19
Implementation of digital home monitoring and management of respiratory disease	19
Group 2 pulmonary hypertension: from diagnosis to treatment	18
Considerations and clinical management of infections in sarcoidosis	18
Editorial introductions	17
Lung transplant referral considerations for individuals with cystic fibrosis	17
The future of clinical trials in idiopathic pulmonary fibrosis	17
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	16
Asthma in pregnancy: a review of recent literature	16
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	16
Cystic fibrosis liver disease in the post-modulator era	15
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	15

Casting light on the many facets of sarcoidosis	14
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	14
Tobacco treatment in the setting of lung cancer screening	14
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	14
What causes cough in pulmonary fibrosis, and how should we treat it?	14
Progress for all: addressing disparities in sarcoidosis	14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	14
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	14
Home monitoring of coronavirus disease 2019 patients in different phases of disease	13
Digital inhalers for asthma management	13
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	13
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	13
Effectiveness and safety of coronavirus disease 2019 vaccines	12
Acute rejection post lung transplant	12
Imaging in peripheral bronchoscopy	12
Editorial: Are we ready for prime time?	12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	12
Exhaled breath analysis in interstitial lung disease	11
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	11
Multidisciplinary care in nonmalignant central airway obstruction	11
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	11
Infection control in cystic fibrosis: evolving perspectives and challenges	11
Patterns of progression in non-IPF fibrotic interstitial lung disease	11
Novel insights in fibrotic pulmonary sarcoidosis	11
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	11
The changing landscape of infections in the lung transplant recipient	10
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	10
Telerehabilitation in pulmonary diseases	10
The association of preexisting severe asthma with COVID-19 outcomes	10
Editorial: ‘What is your occupation?’: historical snippets	10
Altered pharmacology and toxicology during ageing: implications for lung disease	10
Adenotonsillectomy: the good, the bad and the unknown	10
Epigenetics and aging: relevance for sleep medicine	10
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	10
Right ventricular assessment in pulmonary hypertension	9
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	9
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	9
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	9
Approach to the hospitalized patient with pulmonary arterial hypertension	9
Ergonomics in bronchoscopy	9
Prader–Willi syndrome: an update	9
Advancements in airway stents: a comprehensive update	8
Editorial introductions	8
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	8
Long-term safety, durability of response, cessation and switching of biologics	8
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	8
Bronchoscopic lung volume reduction in emphysema: a review	8
Methamphetamine-associated pulmonary arterial hypertension	8

Military deployment-related respiratory problems: an update	8
Editorial introductions	8
Updates in the diagnosis and management of chronic thromboembolic disease	8
Editorial introductions	8
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	7
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	7
Artificial intelligence for the optimal management of community-acquired pneumonia	7
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	7
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	7
Bacteriophages for bronchiectasis: treatment of the future?	7
Role of biomarkers in lung nodule evaluation	7
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	7
Pulmonary alveolar proteinosis – current and future therapeutical strategies	7
Editorial: The role of ageing in pulmonary disease	7
Editorial introductions	7
Editorial introductions	7
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	7
Health inequities in the modulator era	7
Recent advances predict a bright future for nebulizers	7
Bronchoscopic interventions for chronic bronchitis	7
Interstitial lung disease following coronavirus disease 2019	6
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	6
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	6
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	6
What is new in mediastinal staging?	6
Anesthetic considerations in interventional pulmonology	6
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	6
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	6
Indwelling pleural catheters for benign pleural effusions: a concise review	6
Risk stratification of pulmonary embolism	6
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	5
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	5
Recent developments in occupational asthma	5
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	5
Editorial introduction	5
Lung infections due to emerging fungal pathogens	5
Environmental and occupational exposures in interstitial lung disease	5
Editorial introductions	5
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	5
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	4
Whole lung lavage: considerations from the anesthesiology perspective	4
Bedside to bench and back again-translational research in interventional pulmonology	4
Glymphatic MRI techniques in sleep and neurodegenerative diseases	4
Vitamin D deficiency in chronic obstructive pulmonary disease	4
The controversy over daylight saving time: evidence for and against	4
Management of complicated parapneumonic effusions	4
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	4
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	4
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	4
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	4
Leveraging AI technology in sarcoidosis	4
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	4
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	4
Pulmonary adverse events following immune checkpoint inhibitors	4
Sex differences in sleep and sleep-disordered breathing	4
Lung transplantation: practical and important directions of care	4